Yokaichiba, Japan

Junji Ookawa


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junji Ookawa: Innovator in Pharmaceutical Chemistry

Introduction

Junji Ookawa is a notable inventor based in Yokaichiba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve important medical purposes. His work focuses on enhancing the efficacy and safety of analgesic agents.

Latest Patents

One of Junji Ookawa's key patents is for "Phenylacetic ester derivatives and process for preparing the same." This patent describes the production of novel phenylacetic ester derivatives by reacting ketoprofene with alkylene glycol compounds. These derivatives are recognized for their utility as a nonsteroidal antiphlogistic and analgesic agent, offering reduced side effects compared to the sole use of ketoprofene. This innovation highlights his commitment to improving patient care through safer medication options.

Career Highlights

Junji Ookawa is associated with Ss Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His expertise in synthesizing new chemical compounds has positioned him as a valuable asset in the industry. His work not only contributes to the company's portfolio but also enhances the overall landscape of pharmaceutical innovations.

Collaborations

Junji Ookawa has collaborated with esteemed colleagues such as Haruyoshi Honda and Susumu Sato. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.

Conclusion

Junji Ookawa's contributions to pharmaceutical chemistry, particularly through his patent on phenylacetic ester derivatives, demonstrate his dedication to improving medical treatments. His work continues to influence the development of safer and more effective analgesic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…